Astellas Buys Stem Cell Gene-Editing Firm for $102.5M – Xconomy
Xconomy |
Astellas Buys Stem Cell Gene-Editing Firm for $102.5M
Xconomy Universal Cells' technology aims to make stem cells that don't have some of the problems that current cell therapies face, such as the immune rejection of transplanted cells. This is an attractive prospect for Astellas, which has been working to get … Astellas pledges $102.5M for universal donor cell company Astellas Acquires Universal Cells, Inc. Astellas upgrades Universal Cells licensing deal to a buy |
